Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-3180-2018

VITEK(R) 2 AST-P655, For susceptibility testing of Staphylococcus spp. Enterococcus spp., ad S agalactiae against specified antimicrobials, REF 421913 Product Usage: VITEK® 2 is an automated system consisting of instruments, software and reagent cards designed for the identification and antimicrobial susceptibility testing of bacteria and yeast. The VITEK® 2 utilizes growth-based biochemical patterns to determine identification. The VITEK® 2 provides minimal inhibitory concentration (MIC) results for most organism/drug combinations as well as a category interpretation (S, I, or R) consistent with accepted criteria.

Publicado el 26 de septiembre de 2018 · Inicio del retiro: 13 de agosto de 2018

Resumen

FDA registra el retiro Z-3180-2018 de dispositivos médicos de Clase II, publicado el 26 de septiembre de 2018 e iniciado el 13 de agosto de 2018. Empresa responsable: bioMerieux, Inc.; Estado: Finalizado; Cantidad reportada: 10919 cartons; Lote: Lot Numbers: 8050348103, 8050452403, 8050655403, 8050690403. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Routine internal review of Device History Records identified six VITEK(R) 2 AST card lots were manufactured with less drug (gentamicin) than required for the Gentamicin High-Level Resistance (ghlr01n) screen test due to an error when making 1500mL and 2000mL media well preparations (solutions).

Qué hacer

Voluntary: Firm initiated · E-Mail

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
bioMerieux, Inc.
Distribuidor
Worldwide Distribution US Nationwide and the countries of: Turkey, Austria, Switzerland, Czech Republic, Germany, Netherlands,
Lote
Lot Numbers: 8050348103, 8050452403, 8050655403, 8050690403
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿VITEK(R) 2 AST-P655, For susceptibility testing of Staphylococcus spp. Enterococcus spp., ad S agalactiae against specified antimicrobials, REF 421913 Product Usage: VITEK® 2 is an automated system consisting of instruments, software and reagent cards designed for the identification and antimicrobial susceptibility testing of bacteria and yeast. The VITEK® 2 utilizes growth-based biochemical patterns to determine identification. The VITEK® 2 provides minimal inhibitory concentration (MIC) results for most organism/drug combinations as well as a category interpretation (S, I, or R) consistent with accepted criteria. fue retirado del mercado?

Sí. FDA publicó el retiro Z-3180-2018 el 26 de septiembre de 2018. Peligro reportado: Routine internal review of Device History Records identified six VITEK(R) 2 AST card lots were manufactured with less drug (gentamicin) than required for the Gentamicin High-Level Resistance (ghlr01n) screen test due to an error when making 1500mL and 2000mL media well preparations (solutions).

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · E-Mail